Skip to main content
Contact Us
Subscribe
E-Edition
73°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Atara Biotherapeutics, Inc. - Common Stock
(NQ:
ATRA
)
7.307
-0.113 (-1.53%)
Streaming Delayed Price
Updated: 12:33 PM EDT, May 9, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Atara Biotherapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
May 06, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
April 24, 2025
Via
Benzinga
FDA Places Clinical Hold On Atara Biotherapeutics' Two Cell Therapy Programs
January 21, 2025
FDA halts Atara's EBVALLO and ATA3219 trials over manufacturing issues. Atara eyes $60 million milestone from Pierre Fabre upon EBVALLO approval.
Via
Benzinga
Exposures
Product Safety
Nasdaq Down 150 Points; Morgan Stanley Earnings Top Estimates
January 16, 2025
Via
Benzinga
Atara Stock Plunges To 3-Month Low After FDA Blocks Blood Cancer Drug: Retail's Buying The Dip
January 16, 2025
CEO Cokey Nguyen expressed confidence in resolving the issue, expecting resubmission and potential approval within six months of addressing the manufacturing compliance concerns.
Via
Stocktwits
Exposures
Product Safety
Earnings Scheduled For November 12, 2024
November 12, 2024
Via
Benzinga
Insights into Atara Biotherapeutics's Upcoming Earnings
November 11, 2024
Via
Benzinga
Atara Biotherapeutics: Q4 Earnings Insights
March 28, 2024
Via
Benzinga
Crude Oil Down 1%; Bank of America Posts Upbeat Earnings
January 16, 2025
Via
Benzinga
Exposures
Fossil Fuels
US Stocks Edge Lower; Retail Sales Increase Less Than Expected
January 16, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 14, 2025
Via
Benzinga
Crude Oil Down 1%; Dollar Tree Shares Tumble After Downbeat Earnings
September 04, 2024
Via
Benzinga
Exposures
Fossil Fuels
Atara Biotherapeutics (ATRA) Stock Is Up 20%: What's Going On?
September 04, 2024
Atara Biotherapeutics shares are trading higher by 20% Wednesday morning. The company announced a $36 million registered direct offering.
Via
Benzinga
Why GitLab Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
September 04, 2024
Via
Benzinga
ATRA Stock Earnings: Atara Biotherapeutics Misses EPS, Misses Revenue for Q2 2024
August 12, 2024
ATRA stock results show that Atara Biotherapeutics missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
June 17, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
June 17, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
May 31, 2024
Via
Benzinga
ATRA Stock Earnings: Atara Biotherapeutics Beats EPS, Beats Revenue for Q1 2024
May 09, 2024
ATRA stock results show that Atara Biotherapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
May 07, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
April 08, 2024
Via
Benzinga
ATRA Stock Earnings: Atara Biotherapeutics Misses EPS, Misses Revenue for Q4 2023
March 28, 2024
ATRA stock results show that Atara Biotherapeutics missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
March 18, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
March 08, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
March 06, 2024
Via
Benzinga
Why 4D Molecular Therapeutics Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket
February 05, 2024
Shares of 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) rose sharply in today’s pre-market trading. 4DMT presented interim data from randomized Phase 2 PRISM clinical trial of intravitreal 4D-150...
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
February 02, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
February 02, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
January 15, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 25, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
